President Donald Trump has urged a federal emergency agency to approve an anti-malarial drug to treat the more than 10,000 cases in the United States where about 150 people have died.
But regulators say the drug cannot yet treat COVID-19.
Hospitals across the country are still struggling to get enough medical supplies and Trump’s critics say the president should have swung into action a lot sooner.
Al Jazeera’s White House correspondent Kimberly Halkett reports from Washington, DC.
